Effects of interventions on intra- and interobserver agreement on interpretation of nonalcoholic fatty liver disease histology

Annals of Diagnostic Pathology

Volumn 15, Issue 1, 2011, Pages 19-24

  Gawrieh, Samer ^a,b   Knoedler, Darly M ^a   Saeian, Kia ^a   Wallace, James R ^a   Komorowski, Richard A ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Agreement; Interobserver; Intraobserver; NAFLD; NASH; Steatohepatitis; Steatosis

Indexed keywords

ARTICLE; DISEASE CLASSIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; NONALCOHOLIC FATTY LIVER; OBSERVER VARIATION; PHENOTYPE; PRIORITY JOURNAL; SCORING SYSTEM;

BIOPSY; FATTY LIVER; HUMANS; INTERVENTION STUDIES; LIVER CIRRHOSIS; OBSERVER VARIATION; REPRODUCIBILITY OF RESULTS;

EID: 78751575786     PISSN: 10929134     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anndiagpath.2010.08.001     Document Type: Article

References (32)

1. Charlton M. Nonalcoholic fatty liver disease: a review of current understanding and future impact Clin Gastroenterol Hepatol 2 12 2004 1048 1058
2. Clark J.M., Brancati F.L., and Diehl A.M. The prevalence and etiology of elevated aminotransferase levels in the United States Am J Gastroenterol 98 5 2003 960 967
3. Patton H.M., Sirlin C., and Behling C. Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research J Pediatr Gastroenterol Nutr 43 4 2006 413 427
4. Browning J.D., Szczepaniak L.S., and Dobbins R. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity Hepatology 40 6 2004 1387 1395
5. Schwimmer J.B., Deutsch R., and Kahen T. Prevalence of fatty liver in children and adolescents Pediatrics 118 4 2006 1388 1393
6. Brunt E.M. Pathology of nonalcoholic fatty liver disease Nat Rev Gastroenterol Hepatol 7 4 2010 195 203
7. Matteoni C.A., Younossi Z.M., and Gramlich T. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity Gastroenterology 116 6 1999 1413 1419
8. Ekstedt M., Franzen L.E., and Mathiesen U.L. Long-term follow-up of patients with NAFLD and elevated liver enzymes Hepatology 44 4 2006 865 873
9. Sanyal A.J., Banas C., and Sargeant C. Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C Hepatology 43 4 2006 682 689
10. Sanyal A.J., Mofrad P.S., and Contos M.J. A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis Clin Gastroenterol Hepatol 2 12 2004 1107 1115
11. Promrat K., Lutchman G., and Uwaifo G.I. A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis Hepatology 39 1 2004 188 196
12. Younossi Z.M., Gramlich T., and Liu Y.C. Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations Mod.Pathol. 11 6 1998 560 565
13. Kleiner D.E., Brunt E.M., and Van Natta M. Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 6 2005 1313 1321
14. Ratziu V., Charlotte F., and Heurtier A. Sampling variability of liver biopsy in nonalcoholic fatty liver disease Gastroenterology 128 7 2005 1898 1906
15. Merriman R.B., Ferrell L.D., and Patti M.G. Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease Hepatology 44 4 2006 874 880
16. Fukusato T., Fukushima J., and Shiga J. Interobserver variation in the histopathological assessment of nonalcoholic steatohepatitis Hepatol.Res. 33 2 2005 122 127
17. El-Badry A.M., Breitenstein S., and Jochum W. Assessment of hepatic steatosis by expert pathologists: the end of a gold standard Ann.Surg. 250 5 2009 691 697
18. Brunt E.M., Janney C.G., and Di Bisceglie A.M. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions Am.J.Gastroenterol. 94 9 1999 2467 2474
19. Dixon J.B., Bhathal P.S., and O'Brien P.E. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese Gastroenterology 121 1 2001 91 100
20. Fleiss J. Statistical methods for rates and proportions 1981 John Wiley New York
21. Efron B. Jackknife, the bootstrap and other resampling plans 1982 The Society for Industrial and Applied Mathematics Philadelphia
22. Landis J.R., and Koch G.G. An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers Biometrics 33 2 1977 363 374
23. Vuppalanchi R., Teal E., and Chalasani N. Patients with elevated baseline liver enzymes do not have higher frequency of hepatotoxicity from lovastatin than those with normal baseline liver enzymes Am J Med Sci 329 2 2005 62 65
24. Marsman H., Matsushita T., and Dierkhising R. Assessment of donor liver steatosis: pathologist or automated software? Hum Pathol 35 4 2004 430 435
25. Franzen L.E., Ekstedt M., and Kechagias S. Semiquantitative evaluation overestimates the degree of steatosis in liver biopsies: a comparison to stereological point counting Mod Pathol 18 7 2005 912 916
26. Liquori G.E., Calamita G., and Cascella D. An innovative methodology for the automated morphometric and quantitative estimation of liver steatosis Histol Histopathol 24 1 2009 49 60
27. Turlin B., Ramm G.A., and Purdie D.M. Assessment of hepatic steatosis: comparison of quantative and semiquantitative methods in 108 liver biopsies Liver Int 29 4 2009 530 535
28. Dahab G.M., Kheriza M.M., and El-Beltagi H.M. Digital quantification of fibrosis in liver biopsy sections: description of a new method by Photoshop software J Gastroenterol Hepatol 19 1 2004 78 85
29. Nguyen-Khac E., and Capron D. Noninvasive diagnosis of liver fibrosis by ultrasonic transient elastography (Fibroscan) Eur J Gastroenterol Hepatol 18 12 2006 1321 1325
30. Yoneda M., Yoneda M., and Fujita K. Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD) Gut 56 9 2007 1330 1331
31. Yin M., Talwalkar J.A., and Glaser K.J. Assessment of hepatic fibrosis with magnetic resonance elastography Clin Gastroenterol Hepatol 5 10 2007 1207 1213.e2
32. Wong V.W., Vergniol J., and Wong G.L. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease Hepatology 51 2 2010 454 462